SEC CIK 2080625
Kline Kyle
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| GMEDview stock → | 0 | 2026-01-08 |
Position History — GMED
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — GMED
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-01-21 | Grant / award (derivative) | 30,000 | $0.00 | 30,000 |
| 2026-01-08 | Option exercise (derivative) | 3,594 | $0.00 | 3,906 |
| 2026-01-08 | Open-market sale | 3,594 | $101.10 | 0 |
| 2026-01-08 | Option exercise | 3,594 | $51.87 | 3,594 |
| 2025-12-01 | Option exercise (derivative) | 5,000 | $0.00 | 0 |
| 2025-12-01 | Option exercise (derivative) | 5,000 | $0.00 | 10,000 |
| 2025-12-01 | Option exercise (derivative) | 3,646 | $0.00 | 1,354 |
| 2025-12-01 | Open-market sale | 18,542 | $90.00 | 0 |
| 2025-12-01 | Option exercise | 4,896 | $63.68 | 18,542 |
| 2025-12-01 | Option exercise | 5,000 | $64.44 | 13,646 |
| 2025-12-01 | Option exercise | 5,000 | $56.43 | 8,646 |
| 2025-12-01 | Option exercise | 3,646 | $53.14 | 3,646 |
| 2025-12-01 | Option exercise (derivative) | 4,896 | $0.00 | 104 |
| 2025-07-18 | Grant / award (derivative) | 20,909 | $0.00 | 20,909 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.